Teva Pharmaceuticals
TEVA
TEVA
436 hedge funds and large institutions have $4.81B invested in Teva Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 138 increasing their positions, 117 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
436
Holders Change
-12
Holders Change %
-2.68%
% of All Funds
6.9%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
46
Increased
138
Reduced
117
Closed
53
Calls
$383M
Puts
$377M
Net Calls
+$5.19M
Net Calls Change
+$40.4M
Top Buyers
| 1 |
Millennium Management
New York
|
+$82.2M |
| 2 |
EP
Eversept Partners
New York
|
+$17.3M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$17.2M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$16.8M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$15.8M |
